Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3120 | 1786 | 40.5 | 92% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
12393 | 845 | POKEMON//BCL6//HIC1 |
18995 | 460 | BRANCHIO OCULO FACIAL SYNDROME//AP 2//AP 2 ALPHA |
22972 | 306 | RIZ1//PRDM//RIZ |
31875 | 117 | CITED2//CITED//MELANOCYTE SPECIFIC GENE MSG1 |
34954 | 58 | TNFAIP1//KCTD7//KCTD10 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BRANCHIO OCULO FACIAL SYNDROME | Author keyword | 49 | 94% | 1% | 17 |
2 | RIZ1 | Author keyword | 44 | 88% | 1% | 21 |
3 | BCL6 | Author keyword | 40 | 42% | 4% | 72 |
4 | POKEMON | Author keyword | 40 | 72% | 2% | 31 |
5 | CITED2 | Author keyword | 29 | 63% | 2% | 29 |
6 | AP 2 | Author keyword | 22 | 30% | 3% | 61 |
7 | HIC1 | Author keyword | 19 | 60% | 1% | 21 |
8 | AP 2 ALPHA | Author keyword | 19 | 58% | 1% | 22 |
9 | BTB POZ DOMAIN | Author keyword | 19 | 64% | 1% | 18 |
10 | BCL6 GENE | Author keyword | 18 | 89% | 0% | 8 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BRANCHIO OCULO FACIAL SYNDROME | 49 | 94% | 1% | 17 | Search BRANCHIO+OCULO+FACIAL+SYNDROME | Search BRANCHIO+OCULO+FACIAL+SYNDROME |
2 | RIZ1 | 44 | 88% | 1% | 21 | Search RIZ1 | Search RIZ1 |
3 | BCL6 | 40 | 42% | 4% | 72 | Search BCL6 | Search BCL6 |
4 | POKEMON | 40 | 72% | 2% | 31 | Search POKEMON | Search POKEMON |
5 | CITED2 | 29 | 63% | 2% | 29 | Search CITED2 | Search CITED2 |
6 | AP 2 | 22 | 30% | 3% | 61 | Search AP+2 | Search AP+2 |
7 | HIC1 | 19 | 60% | 1% | 21 | Search HIC1 | Search HIC1 |
8 | AP 2 ALPHA | 19 | 58% | 1% | 22 | Search AP+2+ALPHA | Search AP+2+ALPHA |
9 | BTB POZ DOMAIN | 19 | 64% | 1% | 18 | Search BTB+POZ+DOMAIN | Search BTB+POZ+DOMAIN |
10 | BCL6 GENE | 18 | 89% | 0% | 8 | Search BCL6+GENE | Search BCL6+GENE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FINGER ENCODING GENE | 127 | 58% | 8% | 145 |
2 | POZ DOMAIN | 85 | 58% | 5% | 98 |
3 | 3Q27 TRANSLOCATION | 69 | 96% | 1% | 22 |
4 | FACTOR AP 2 | 58 | 47% | 5% | 91 |
5 | TRANSCRIPTION FACTOR AP 2 | 52 | 33% | 7% | 131 |
6 | BTB POZ DOMAIN | 52 | 48% | 4% | 80 |
7 | PROTEIN INTERACTION MOTIF | 50 | 57% | 3% | 60 |
8 | AP 2 ALPHA | 48 | 70% | 2% | 40 |
9 | AP 2 BETA | 44 | 88% | 1% | 21 |
10 | BTB DOMAIN | 41 | 46% | 4% | 67 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The generation of antibody-secreting plasma cells | 2015 | 6 | 155 | 25% |
Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis | 2014 | 9 | 72 | 60% |
Roles of BCL6 in normal and transformed germinal center B cells | 2012 | 67 | 82 | 57% |
BCL6: Master Regulator of the Germinal Center Reaction and Key Oncogene in B Cell Lymphomagenesis | 2010 | 85 | 77 | 60% |
Regulation and functions of blimp-1 in T and B lymphocytes | 2008 | 166 | 161 | 40% |
The AP-2 family of transcription factors | 2005 | 149 | 77 | 73% |
The genetic network controlling plasma cell differentiation | 2011 | 59 | 95 | 37% |
BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint | 2014 | 3 | 82 | 63% |
POZ for effect - POZ-ZF transcription factors in cancer and development | 2006 | 134 | 91 | 52% |
Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control | 2000 | 197 | 69 | 72% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROGRAM ONCOGENES TUMOR SUPP SOR GENES | 9 | 67% | 0.4% | 8 |
2 | DEV GENET H2 | 7 | 38% | 0.8% | 15 |
3 | BIOCHEM MOL BIOLBRAIN KOREA PLUS PROJECT | 3 | 100% | 0.2% | 3 |
4 | SEVERANCE BIOMED MED | 3 | 100% | 0.2% | 3 |
5 | CRANIO IAL BIOL CELL DEV BIOL | 3 | 42% | 0.3% | 5 |
6 | DIABET NEPHROL | 2 | 67% | 0.1% | 2 |
7 | INTEGRATED PROGRAM BIOPHYS CELLULAR MOL STUDIES | 2 | 67% | 0.1% | 2 |
8 | INTEGRATED PROGRAM CELLULAR MOL BIOPHYS SCI | 2 | 67% | 0.1% | 2 |
9 | PROT CHEM DEV BIOL STATE EDUC MINIST CH | 2 | 67% | 0.1% | 2 |
10 | TIEFENAU S | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000013954 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//SUMO |
2 | 0.0000012827 | ID 1//NRSF//MYC |
3 | 0.0000011970 | MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA |
4 | 0.0000011758 | SERUM RESPONSE FACTOR//MYOCARDIN//KLF4 |
5 | 0.0000011723 | CAS9//GENOME EDITING//CRISPR |
6 | 0.0000010777 | AGR2//ALCAM//GICERIN |
7 | 0.0000010579 | ETS 1//PU1//HEMANGIOBLAST |
8 | 0.0000010100 | DLX4//DLX3//CANC DEV BIOL MATERNAL FETAL BIOL |
9 | 0.0000008811 | SOMATIC HYPERMUTATION//VDJ RECOMBINATION//CLASS SWITCH RECOMBINATION |
10 | 0.0000008770 | CHROMATIN SUPRAORGANIZATION//ZNF703//NUCLEAR PHENOTYPES |